Literature DB >> 16247308

BMP-14 deficiency inhibits long bone fracture healing: a biochemical, histologic, and radiographic assessment.

Anikar Chhabra1, David Zijerdi, Jianxin Zhang, Alex Kline, Gary Balian, Shephard Hurwitz.   

Abstract

OBJECTIVES: Bone morphogenetic proteins (BMPs) represent a distinct subset of the transforming growth factor-beta family best known for their role in joint formation and bone growth, and several recent clinical trials have begun to look at their efficacy in the augmentation of fracture healing. The goal of this research is to examine the effect of BMP-14, also known as growth differentiation factor-5 and cartilage- derived morphogenetic protein-1 (GDF-5, CDMP-1) on fracture healing by studying the long bone repair process in mice with a deficiency in this signaling peptide.
METHODS: The animal model used for these studies was the BMP-14 (-/-) brachypodism (bp) mouse. Phenotypically normal heterozygous (+/-) littermates were used as controls. Closed mid shaft femur fractures were created and stabilized with intramedullary fixation in 8-week-old female mice. Forty-eight mice per genotype group were examined. On postoperative days 4, 7, 10, 14, 21, 28, 35, and 42, the mice were killed and the femurs and repair tissue were harvested for analysis. At each time point, the fracture sites were analyzed radiographically, histologically, and biochemically. For all quantitative analyses, the data were normalized and analyzed statistically using a 2-factor ANOVA test.
RESULTS: Biochemically, peak values of normalized proteoglycan content were approximately 3 times less in the mutant fractures early in the time course of healing compared with the controls (P < 0.05). Histologically, BMP-14-deficient fractures exhibited a delay in peak area cell density, callus organization, and bone formation compared with controls. Radiographic analysis demonstrated that the peak callus was 2 weeks delayed and approximately 2 times less in the mutants compared with controls (P < 0.05). Radiographic grading of callus also demonstrated a significant difference after day 14.
CONCLUSIONS: Based on histologic, radiographic, and biochemical analysis, BMP-14-deficient mice display a short-term delay in healing of approximately 1 to 2 weeks. The observed abnormalities seem to be the result of a delay in cellular recruitment and chondrocyte differentiation in the early stages fracture repair in the absence of BMP-14. These results support the hypothesis that BMP-14 deficiency leads to a delay in fracture healing. Further studies are warranted to more closely examine the role of BMP-14 in normal fracture healing and the mechanism by which it works.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247308     DOI: 10.1097/01.bot.0000177108.38461.9c

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  18 in total

1.  Insulin-like growth factor-I and growth differentiation factor-5 promote the formation of tissue-engineered human nasal septal cartilage.

Authors:  Thomas H Alexander; August B Sage; Albert C Chen; Barbara L Schumacher; Elliot Shelton; Koichi Masuda; Robert L Sah; Deborah Watson
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

2.  Regional and cellular localisation of BMPs and their inhibitors' expression in human fractures.

Authors:  Francois N K Kwong; Judith A Hoyland; Christopher H Evans; Anthony J Freemont
Journal:  Int Orthop       Date:  2008-11-21       Impact factor: 3.075

Review 3.  Bone morphogenetic proteins in fracture repair.

Authors:  Ivo Dumic-Cule; Mihaela Peric; Lucija Kucko; Lovorka Grgurevic; Marko Pecina; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2018-09-15       Impact factor: 3.075

4.  Bioactive factors in platelet-rich plasma obtained by apheresis.

Authors:  Jan Philipp Krüger; Undine Freymannx; Samuel Vetterlein; Katja Neumann; Michaela Endres; Christian Kaps
Journal:  Transfus Med Hemother       Date:  2013-10-27       Impact factor: 3.747

5.  Delayed fracture healing in growth differentiation factor 5-deficient mice: a pilot study.

Authors:  Cynthia M Coleman; Brooke H Scheremeta; Amanda T Boyce; Robert L Mauck; Rocky S Tuan
Journal:  Clin Orthop Relat Res       Date:  2011-05-18       Impact factor: 4.176

Review 6.  Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification.

Authors:  Favour Felix-Ilemhenbhio; George A E Pickering; Endre Kiss-Toth; Jeremy Mark Wilkinson
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

7.  Altered relative expression of BMPs and BMP inhibitors in cartilaginous areas of human fractures progressing towards nonunion.

Authors:  Francois N K Kwong; Judith A Hoyland; Anthony J Freemont; Christopher H Evans
Journal:  J Orthop Res       Date:  2009-06       Impact factor: 3.494

Review 8.  New advances in musculoskeletal pain.

Authors:  Susan E Bove; Sarah J L Flatters; Julia J Inglis; Patrick W Mantyh
Journal:  Brain Res Rev       Date:  2008-12-25

9.  The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383.

Authors:  Catherine M Syddall; Louise N Reynard; David A Young; John Loughlin
Journal:  PLoS Genet       Date:  2013-06-27       Impact factor: 5.917

10.  Acute phosphate restriction leads to impaired fracture healing and resistance to BMP-2.

Authors:  Nathan A Wigner; Hilary F Luderer; Megan K Cox; Karen Sooy; Louis C Gerstenfeld; Marie B Demay
Journal:  J Bone Miner Res       Date:  2010-04       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.